Tham khảo tài liệu 'báo cáo hóa học: " downregulation of apobec3g by xenotropic murine leukemia-virus related virus (xmrv) in prostate cancer cells"', luận văn - báo cáo phục vụ nhu cầu học tập, nghiên cứu và làm việc hiệu quả | Virology Journal BioMed Central Vz The Open Access Publisher This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text HTML versions will be made available soon. Downregulation of APOBEC3G by Xenotropic Murine Leukemia-Virus Related Virus XMRV in Prostate Cancer Cells Virology Journal 2011 8 531 doi 1743-422X-8-531 Abhinav Dey abhinavdey@ Chinmay K Mantri cmantri@ Jui Pandhare-Dash jpandhare@ Bindong Liu bliu@ Siddharth Pratap spratap@ Chandravanu Dash cdash@ ISSN Article type Submission date Acceptance date Publication date Article URL 1743-422X Short report 26 September 2011 12 December 2011 12 December 2011 http This peer-reviewed article was published immediately upon acceptance. It can be downloaded printed and distributed freely for any purposes see copyright notice below . Articles in Virology Journal are listed in PubMed and archived at PubMed Central. For information about publishing your research in Virology Journal or any BioMed Central journal go to http authors instructions For information about other BioMed Central publications go to http 2011 Dey et al. licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Downregulation of APOBEC3G by Xenotropic Murine Leukemia-Virus Related Virus XMRV in Prostate Cancer Cells ArticleCategory Short Report ArticleHistory Received 26-Sep-2011 Accepted 22-Nov-2011 ArticleCopyright 2011 Dey et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and .
